|
|
| Dimensions: 5.5 x 8.5 |
 |
| 113 pages |
|
|
AEI Press
(Washington)
|
|
| Publication Date: May 2008 |
|
|
| Paperback |
| ISBN: 978-0-8447-4264-9 |
| Price: $ 15.00 |
Add to Cart  |
|
| Examination Copies |
|
|
|
|
Click here to view Making a Killing as an Adobe Acrobat PDF
Click here to view the press release for Making a Killing
Counterfeit pharmaceuticals kill hundreds of thousands of people every year. Although most pervasive in poor countries, counterfeit drug trafficking is a worrying new phenomenon in the developed world. Payoffs for counterfeiters are high--the global market amounts to billions of dollars per year--and potential punishment is slight compared to the strict penalties facing narcotics dealers. From Internet pharmacies frequented by American consumers to the back streets of New Delhi, counterfeit drug trafficking is a complex, deadly, and increasingly lucrative industry that is becoming an attractive arena for organized crime.
In this groundbreaking study, Roger Bate traces pharmaceutical counterfeiting around the world, from developed nations, where counterfeits often target "lifestyle" drugs such as Viagra, to developing countries, where counterfeiters favor therapeutic medicines such as antimalarials and antibiotics. Enforcement in developing nations is hampered by inadequate education, feeble regulation, and sluggish policing of existing laws. The United States is struggling to thwart an insidious Internet market.
Making a Killing: The Deadly Implications of the Counterfeit Drug Trade champions greater cooperation between wealthy and poor nations to quash the trade in counterfeit pharmaceuticals. Bate calls for fortified policing resources, harsher penalties for counterfeiters, widespread public education, and commonsense consumer vigilance against this danger. Western policymakers must act immediately to quell the deadly counterfeit market in developing countries--and to ensure the integrity of their products at home.
Roger Bate is a resident fellow at AEI. He writes extensively on topics such as endemic diseases in developing countries (malaria, HIV/AIDS); access and innovation in pharmaceuticals; taxes and tariffs; water policy; and international health agreements.
Table of Contents
Introduction: The Second-Oldest Profession
Definitions and Scope
1. Counterfeiting Today
Counterfeit Drugs in Industrialized Economies
Compromised Supply Chains
Internet Sales
Drugs Targeted
Counterfeit Drugs in Developing Countries
Africa
Latin America
Russia
Asia
2. How and Why Does Counterfeiting Occur?
Incentives to Counterfeit
Corruption within Countries
Complex Supply Chains Encourage Fakes
Developed Countries
Developing Countries
Counterfeiting, Organized Crime, and Terrorism
Conclusion
3. Stopping the Fakers
At the International Level
At the National Level
Developed Countries
Japan
United States
European Union
Developing Countries
Africa
Latin America
Russia
Asia
Unilateral Private Action
Independent Organizations
Pharmaceutical Companies
Pharmacists
4. Policy Recommendations
At the International Level
Donor Agencies
Aid Agencies
At the National Level
Developing Countries
Western Countries
Public and Private Actors
Governments
Policymakers
At the Business Level
Pharmaceutical Companies
At the Individual Level
Public-Private Cooperation
Conclusion
